tiprankstipranks
Immuneering (IMRX)
NASDAQ:IMRX
US Market
Holding IMRX?
Track your performance easily

Immuneering (IMRX) Stock Investors

280 Followers
Based on 769,002 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold IMRX
On average, investors allocate 0.00% of their portfolios to IMRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,002 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IMRX

3.7%
Last 7
Days
7.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding IMRX, out of 769,002 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IMRX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,689 investors who made their portfolios public
The table shows changes in IMRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IMRX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.53%
+0.19%
+7.08%
5.74B
Healthcare
Marathon Digital Holdings
5.67%
+1.72%
+5.82%
6.39B
Financial
Enphase Energy
4.53%
-0.55%
+2.56%
8.29B
Technology
Abbott Laboratories
3.55%
+0.14%
+11.41%
203.16B
Healthcare
PDD Holdings
5.07%
-0.31%
-2.47%
163.43B
Consumer Cyclical
DraftKings
5.47%
-1.55%
+0.62%
38.05B
Consumer Cyclical
Robinhood Markets
5.22%
+2.25%
+13.11%
31.15B
Technology
AppLovin
6.38%
+4.10%
+15.39%
107.79B
Technology
Nu Holdings
5.10%
+0.41%
+9.67%
63.92B
Financial
Block
4.46%
+0.68%
+2.99%
56.87B
Technology
Based on the activity of 769,002 active portfolios
Open your Smart Portfolio

IMRX Investor Analysis

IMRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.5%
of IMRX holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
IMRX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
23.1%
of IMRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
IMRX investors over 55

Over 55

3.1%
Last 30 days
Holdings Change
65.4%
of IMRX holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of IMRX stock investors
See who invests in IMRX according to age group and performance.

FAQ

How many retail Investors hold IMRX?
<0.1% of TipRanks' retail investors hold IMRX in their portfolios.
    What is IMRX Investor Sentiment?
    IMRX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of IMRX in the last 7 days?
      ▼ 3.7% of TipRanks' retail investors changed their holding of IMRX in the last 7 days.
        What percentage of retail investors changed their holding of IMRX in the last 30 days?
        ▼ 7.8% of TipRanks' retail investors changed their holding of IMRX in the last 30 days.
          What is the average age of retail investors who hold IMRX?
          The average age of IMRX Holders is over 55.
            What other stocks have IMRX investors also bought?
            IMRX Investors also bought VKTX, MARA, ENPH, ABT, PDD, DKNG, HOOD, APP, NU, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              CRMDCormedix
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis